BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study ...
In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...
Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...
Researchers identified LENG8 as a key RNA quality control protein that prevents defective RNA from leaving the nucleus. By ...
Many RNA programs are under increasing pressure to compress development timelines while ensuring consistent RNA quality and ...
Facioscapulohumeral muscular dystrophy (Facio-face; scapulo-scapula or shoulder blade; humeral-arm muscles around the humerus) or FSHD is an inherited muscle disorder characterized by the progressive ...
The advent of the spatial omics era has enabled researchers to acquire vast amounts of transcriptomics and proteomics data. The abundance of a transcript, however, does not necessarily display strong ...
Morning Overview on MSN
Study shows chemo drug azacitidine damages RNA in stressed cells
The chemotherapy drug azacitidine, a frontline treatment for blood cancers such as myelodysplastic syndromes and acute ...
Researchers demonstrate that a circular RNA-based AAV platform significantly enhances gene expression in vivo compared with conventional mRNA approaches.
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results